Last update:

Weight management news

Is poor sleep contributing to the country's weight issues?

Some 70% of teens trying to adapt to a fall schedule are missing out on sleep. Early bells and tough classes combine with delayed biological clocks during adolescence, keeping their nightly sleep duration during the school ...

GLP-1 use among young children with obesity in US remains rare but is rising rapidly

Although the number of U.S. children under age 12 with obesity who are prescribed the weight-loss drugs Saxenda, Wegovy and Zepbound remains low, it was 310 times higher in June 2026 than in 2019, when the drugs were first ...

Some hair loss in men is linked to weight loss drug use

Men already genetically at risk for the most common form of hair loss have a 7% added risk of losing their hair if they use drugs like Ozempic, Wegovy and Zepbound for type 2 diabetes and obesity, a new study shows.

Why men can struggle with weight-loss initiatives

A new study has identified why many men struggle with weight loss, finding that traditional diet programs are often perceived as too restrictive and primarily aimed at women. The research, published in PLOS One and led by ...

GLP-1 meds prompt rethink of obesity and eating disorder care

Obesity and eating disorders have traditionally been treated as separate areas of health care—but the rapid rise of GLP-1 medicines is increasingly bringing the two together. Adelaide University researchers say the growing ...

The critical role of exercise in the GLP-1 era

As GLP-1 receptor agonists reshape obesity treatment, a new medical perspective published in JAMA, underscores a persistent gap in care: integrating exercise into weight management in ways patients can sustain.

Gut hormone FGF15 changes how mice respond to weight loss

Nearly 40% of the population in the United States develop obesity, which is linked to the development of several diseases, including type 2 diabetes and metabolic liver disease. The rise in obesity is, in part, caused by ...

The GLP-1 paradox: Weight loss drugs may lead to stigma

Glucagonlike peptide-1 (GLP-1) medications have taken over the national conversation around weight loss. From celebrity headlines to everyday conversations, GLP-1 drugs like Ozempic and Wegovy are often framed as breakthroughs ...

What to know about GLP-1 drugs for weight loss and health

As many of us know, keeping weight in check can be hard. National numbers certainly reflect this. Rates of overweight and obesity in the U.S. have steadily climbed since the early 1980s. The impact this has had on health ...

Obesity decreases lung function in older adults

In a new study, researchers found that older adults with obesity had significantly decreased measures of lung function compared to those without obesity, and the results were consistent among men and women. These results ...

Semaglutide improves vascular responsiveness to insulin

Glucagon-like peptide-1 receptor agonists, known as GLP-1 drugs, are highly effective at helping people lose weight and substantially lower the risk of heart attacks, strokes, and death from heart disease. A new study conducted ...